RJH Biosciences is focused on realizing the full potential of gene medicine for human health by developing vehicles to effectively deliver nucleic acids. We develop novel transfection agents that deliver different types of nucleic acids to a range of human cells in culture, while tailoring the transfection agents further to act as delivery vehicles for preclinical models and clinical therapy involving nucleic acids.